Concerns Over mRNA Vaccines and Regulatory Accountability

This chapter critically analyzes the risks associated with mRNA technology, particularly focusing on claims made by the FDA regarding its safety. It highlights historical documents and alarming trends in cardiac events post-vaccine rollout, while questioning the transparency and accountability of health authorities. The discussion extends to broader concerns about public health policies influenced by corporate interests and the implications of genetic therapies in future medical practices.